To launch a drug in the ultra-rare disease space, the path to commercialization is narrow. In developing the first treatment ...
Advances show promise for patients with smoldering multiple myeloma, chronic lymphocytic leukemia and acute myeloid leukemia.
Stock futures edged lower Monday morning as investors eye this week’s key inflation report. The Consumer Price Index (CPI) ...
ClearPoint's laser therapy and drug delivery businesses are set for strong growth in 2025. Explore more details here.
The National Medical Commission (NMC) has released its first-ever set of guidelines to identify "fake patients" in medical ...
(NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient ...
CurePSP, Inc. ("CurePSP") and GemVax & KAEL Co., Ltd. ("GemVax"; KOSDAQ: 082270) have announced the establishment of Korea's ...
Health hubs for women will be set up in every part of the country in an effort to close the gender health gap.
Lesley spent more than four years at Merck & Co. (NYSE: MRK) and about 19 years at the Genomics Institute of the Novartis ...
8, 2024 — Patients with acute myeloid leukemia who have lower education and income are less likely to receive a allogeneic hematopoietic ... and/or therapies that have not been approved for commercial ...
Nvidia experts across accelerated computing, data science and research predict multimodal models will speed industry innovation and efficiency. From boardroom to break room, generative AI took this ...
On September 5, 2024, the four-year-old Galam Gatuluak, in the company of her father, Gatuluak Koang, rang a bell to ...